| Product Code: ETC6087558 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Antimicrobial Resistance Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Angola Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Angola Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Angola Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Angola Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Angola Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Angola Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Angola |
4.2.2 Growing awareness about the impact of antimicrobial resistance on public health |
4.2.3 Government initiatives to combat antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Angola |
4.3.2 Lack of proper regulations and enforcement to control the use of antimicrobials |
4.3.3 High cost of antimicrobial resistance treatments |
5 Angola Antimicrobial Resistance Market Trends |
6 Angola Antimicrobial Resistance Market, By Types |
6.1 Angola Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Angola Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Angola Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Angola Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Angola Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Angola Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Angola Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Angola Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Angola Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Angola Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Angola Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Angola Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Angola Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Angola Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Angola Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Angola Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Angola Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Angola Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Angola Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Angola Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Angola Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Angola Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Angola Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Angola Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Angola Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Angola Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Angola Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Angola Antimicrobial Resistance Market Export to Major Countries |
7.2 Angola Antimicrobial Resistance Market Imports from Major Countries |
8 Angola Antimicrobial Resistance Market Key Performance Indicators |
8.1 Number of antibiotic-resistant infections reported annually |
8.2 Percentage of healthcare facilities in Angola with antimicrobial stewardship programs |
8.3 Government spending on antimicrobial resistance initiatives |
9 Angola Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Angola Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Angola Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Angola Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Angola Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Angola Antimicrobial Resistance Market - Competitive Landscape |
10.1 Angola Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Angola Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here